Primary (Neo-Adjuvant) combined modality therapy in the management of locally advanced squamous cell carcinoma of the head and neck (Englisch)
- Neue Suche nach: Mantovani, G.
- Neue Suche nach: Proto, E.
- Neue Suche nach: Contini, L.
- Neue Suche nach: Littera, S.
- Neue Suche nach: Curreli, L.
- Neue Suche nach: Cossu, F.
- Neue Suche nach: Puxeddu, P.
- Neue Suche nach: Del Giacco, G. S.
- Neue Suche nach: Mantovani, G.
- Neue Suche nach: Proto, E.
- Neue Suche nach: Contini, L.
- Neue Suche nach: Littera, S.
- Neue Suche nach: Curreli, L.
- Neue Suche nach: Cossu, F.
- Neue Suche nach: Puxeddu, P.
- Neue Suche nach: Del Giacco, G. S.
- Neue Suche nach: Banzet, P.
In:
Anticancer chemotherapy; Cancer treatment an update
;
201-206
;
1994
-
ISBN:
- Aufsatz (Konferenz) / Print
-
Titel:Primary (Neo-Adjuvant) combined modality therapy in the management of locally advanced squamous cell carcinoma of the head and neck
-
Beteiligte:Mantovani, G. ( Autor:in ) / Proto, E. ( Autor:in ) / Contini, L. ( Autor:in ) / Littera, S. ( Autor:in ) / Curreli, L. ( Autor:in ) / Cossu, F. ( Autor:in ) / Puxeddu, P. ( Autor:in ) / Del Giacco, G. S. ( Autor:in ) / Banzet, P.
-
Kongress:International congress; 4th, Anticancer chemotherapy; Cancer treatment an update ; 1993 ; Paris
-
Erschienen in:
-
Verlag:
- Neue Suche nach: Springer Verlag
-
Erscheinungsdatum:01.01.1994
-
Format / Umfang:6 pages
-
ISBN:
-
Medientyp:Aufsatz (Konferenz)
-
Format:Print
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis Konferenzband
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 3
-
The pathogenesis of human cancer metastasisFidler, I. J. et al. | 1994
- 7
-
The role of molecular genetics in medical oncologyFreireich, E. J. et al. | 1994
- 10
-
Cell line-based screening for new anticancer drugsChabner, B. A. / Weinstein, J. N. / Paull, K. D. / Grever, M. R. et al. | 1994
- 17
-
Anti-EGF receptor monoclonal antibodies as potential anti-cancer therapyMendelsohn, J. et al. | 1994
- 19
-
Clinical relevance of drug resistance: Where do we stand now and where are we going to?Linn, S. C. / Giaccone, G. / Pinedo, H. M. et al. | 1994
- 24
-
Mobilization, purification and ex vivo expansion of human peripheral blood progenitor cellsBrugger, W. / Mertelsmann, R. / Kanz, L. et al. | 1994
- 29
-
Fluoropyrimidine cancer chronotherapyHrushesky, W. J. M. / Cope, F. O. et al. | 1994
- 40
-
Chemo-immunotherapy of metastatic malignant melanoma. The Salpetriere Hospital (SOMPS) experienceKhayat, D. / Antoine, E. / Rixe, O. / Tourani, J. M. / Vuillemin, E. / Borel, C. / Benhammouda, A. / Thill, L. / Franks, C. / Auclerc, G. et al. | 1994
- 47
-
Concomitant chemoradiotherapy for solid tumorsVokes, E. E. / Stupp, R. et al. | 1994
- 50
-
Current status of therapy for small cell carcinoma of the lungIhde, D. C. et al. | 1994
- 55
-
Systemic treatment of bladder cancerDirix, L. Y. / van Oosterom, A. T. et al. | 1994
- 62
-
Metastatic breast cancer: current management options and future directionsHortobagyi, G. et al. | 1994
- 66
-
Present and future prospects for the chemotherapy of gliomasLevin, V. et al. | 1994
- 70
-
Neo-Adjuvant chemotherapy in breast cancer. Study of 477 evaluable patients with primary breast cancers treated between 1980 and 1992Weil, M. / Auclerc, G. / Borel, C. / Baillet, F. / Thomas, A. / Soubrane, C. / Housset, M. / Nizri, D. / Rixe, O. / Antoine, E. et al. | 1994
- 79
-
Osteogenic sarcoma: a 15-year experience in treating 287 patients with preoperative chemotherapyRosen, G. / Lowenbraun, S. / Forscher, C. et al. | 1994
- 85
-
Cell cycle regulation and the chemosensitivity of cancer cellsKohn, K. W. / O Connor, P. M. et al. | 1994
- 90
-
Reversal of multidrug resistance of hematologic malignancies with chemosensitizers: laboratory and clinical studiesSalmon, S. E. / Miller, T. P. / List, A. F. / Grogan, T. M. / Dalton, W. S. et al. | 1994
- 98
-
Practical approach to bladder cancerDenis, L. et al. | 1994
- 105
-
Primary chemotherapy for breast cancer: response to preoperative chemotherapy as prognostic factorHortobagyi, G. N. / Buzdar, A. U. / Frye, D. / Singletary, S. E. / Holmes, F. A. / Ames, F. / McNeese, M. D. / Theriault, R. L. et al. | 1994
- 110
-
Breast cancer, cytoprognostic grades and proliferative activity (DNA ploidy, S phase)de Maublanc, M. A. et al. | 1994
- 114
-
Primary chemotherapy in the individualized non-multilating treatment of breast cancerPoisson, R. / Legault, S. / Guevin, R. et al. | 1994
- 120
-
Neo-Adjuvant chemotherapy in 100 patients with locally advanced carcinoma of the breastCoudert, B. / Gabez, P. / Lamaille, C. / De Gislain, C. / Mayer, F. / Fargeot, P. et al. | 1994
- 123
-
Surgical aspects of the conservative treatment of large size breast cancer after primary chemotherapyZurrida, S. / Greco, M. / Galimberti, V. / Veronesi, U. et al. | 1994
- 127
-
Efficacy of a chemotherapy regimen combining Vinorelbine, Epirubicine and Methotrexate (VEM) in locally advanced and metastatic breast cancerVan Praagh, J. / Martineau, N. / Feillel, V. / Cure, H. / Belembaogo, E. / Ravoux, M. A. / Fleury, J. / Deloche, C. / Plagne, R. / Chollet, P. et al. | 1994
- 131
-
Recurrent breast carcinoma after conservative treatment: MRI features and pathologic correlationDao, T.-H. / Campana, F. / Fourquet, A. / Laurent, M. / Asselain, B. / Rahmouni, A. et al. | 1994
- 135
-
Intensive chemotherapy for inflammatory breast cancer: how much clinical value?Chevallier, B. / Couteau, C. / Atlan, D. / Chatikhine, V. / Graic, Y. / Julien, J.-P. / Kunlin, A. / Bastit, P. / Veyret, C. / D Anjou, J. et al. | 1994
- 146
-
A Phase II study of 2-weekly high-dose Epirubicin with r-met-hu G-CSF in advanced breast cancerFountzilas, G. / Skarlos, D. / Giannakakis, T. / Athanasiades, A. / Bafaloukos, D. / Protopsaltis, J. / Beer, M. / Pavlidis, N. / Kosmidis, P. et al. | 1994
- 150
-
Cyclophosphamide, Novantrone, Fluorouracil (CNF) + G-CSF Neo-Adjuvant chemotherapy in operable breast cancerLorusso, V. / De Lena, M. / Brandi, M. / Longo, S. / Berardi, F. / Catino, A. / Sapia, M. G. / Simone, G. / Marzullo, F. / Racanelli, A. et al. | 1994
- 155
-
Adjuvant chemohormonal therapy with Cyclophosphamide, Doxorubicin and 5-Fluorouracil (CAF) with or without medroxyprogesterone acetate (MPA) in node-positive breast cancer patientsHupperets, P. / Wils, J. / Volovics, L. / Schouten, L. / Fickers, M. / Bron, H. / Schouten, H. / Jager, J. / Smeets, J. / de Jong, J. et al. | 1994
- 160
-
Follow-up results of an ECOG study of adjuvant therapy in postmenopausal women with breast cancerFalkson, H. C. / Gray, R. / Wolberg, W. H. / Falkson, G. et al. | 1994
- 163
-
Long-term efficacy and late sequelae of Doxorubicin-containing adjuvant therapy for breast cancer: MD Anderson Cancer Center studiesBuzdar, A. / Hortobagyi, G. / Kau, S. / Holmes, F. / Fraschini, G. / Theriault, R. / McNeese, M. / Singletary, S. et al. | 1994
- 167
-
Taxol in metastatic breast cancer: the MD Anderson Cancer Center experienceHolmes, F. A. / Valero, V. / Walters, R. / Theriault, R. / Booser, D. / Buzdar, A. / Gibbs, H. / Frye, D. / Young, K. / Hortobagyi, G. et al. | 1994
- 172
-
Taxol plus recombinant human granulocyte colony stimulating factor as salvage chemotherapy for metastatic breast cancerSeidman, A. D. / Reichman, B. S. / Crown, J. P. A. / Yao, T.-J. / Currie, V. / Hakes, T. B. / Hudis, C. A. / Gilewski, T. A. / Forsythe, P. / Lepore, J. et al. | 1994
- 179
-
A model for chemosentivity testing using in vitro MTT assay on a human squamous carcinoma tongue cell lineKing, W. K. W. / Lam, P. K. / Li, K. C. A. et al. | 1994
- 185
-
Head and neck cancer treatment: present status and future directionAl-Sarraf, M. et al. | 1994
- 191
-
Chemotherapy (CT) followed by radiotherapy (RT) vs. RT alone in patients with resected and negative margins squamous cell carninoma of the head and neck: Phase III Intergroup StudyAl-Sarraf, M. / Scott, C. B. / Ahmad, K. / Schwade, J. G. / Schuller, D. / Laramore, G. E. / Jacobs, J. et al. | 1994
- 196
-
Neo-Adjuvant infusion Cisplatin, 5-FU and high-dose leucovorin for squamous cell carcinoma of the head and neck (SCCHN): high rates of complete response (CR) and definitive radiotherapy as primary site managementClark, J. / Dreyfuss, A. / Busse, P. / Norris, C. / Lucarini, J. / Rossi, R. / Andersen, J. / Casey, D. / Frei, E. et al. | 1994
- 201
-
Primary (Neo-Adjuvant) combined modality therapy in the management of locally advanced squamous cell carcinoma of the head and neckMantovani, G. / Proto, E. / Contini, L. / Littera, S. / Curreli, L. / Cossu, F. / Puxeddu, P. / Del Giacco, G. S. et al. | 1994
- 207
-
A Phase II trial of induction Cisplatin, 5-FU, Leucovorin and Interferon-alpha-2B (PFL-alpha) followed by concurrent Hydroxyurea, 5-FU and radiation for Stage IV squamous cell cancers of the head and neck (HNC)Kies, M. S. / Haraf, D. J. / Mittal, B. / Athanasiadis, I. / Kozloff, M. / McEvilly, J. / Mick, R. / Moran, W. / Panje, W. / Pelzer, H. et al. | 1994
- 211
-
Induction chemotherapy with Cisplatin (P), 5-Fluorouracil (FU) and Folinic Acid (FA) in locally advanced head and neck cancerFonseca, E. / Cruz, J.-J. / Garcia, J. / Panadero, A. / Sanchez, P. / Gomez, A. / Martin, G. / Garcia, M.-J. / Vallejo, J.-C. et al. | 1994
- 214
-
A randomized study of CDDP and 5-FU as Neo-Adjuvant chemotherapy in head and neck cancer: an interim analysisMartin, M. / Vergnes, L. / Lelievre / Michel-Langlet, P. / Peytral, C. / Mazeron, J.-J. / Malaurie, E. / Peynegre, R. et al. | 1994
- 219
-
Concomitant chemoradiotherapy in locally advanced head and neck cancers: a prospective study of 68 patientsWalter, S. / Hennequin, C. / Brette, M. D. / Leblanc, P. / Cheriff-Cheikh, P. Y. / Espie, M. / Monteil, J.-P. / Marty, M. / Maylin, C. et al. | 1994
- 225
-
Epidermal growth factor receptor in upper aerodigestive tract cancerFormento, J.-L. / Francoual, M. / Dassonville, O. / Santini, J. / Ramaioli, A. / Milano, G. / Schneider, M. / Demard, F. et al. | 1994
- 234
-
Concomitant alpha-Interferon and chemotherapy in advanced squamous cell carcinoma of the head and neckBenasso, M. / Merlano, M. / Blengio, F. / Cavallari, M. / Rosso, R. / Toma, S. et al. | 1994
- 237
-
Thymidylate synthase activity and Folate levels in head and neck squamous cell carcinomasParise, O. / Janot, F. / Luboinski, B. / Verjus, M.-A. / Gouyette, A. / Cabot, G.-G. et al. | 1994
- 243
-
Long term nephrotoxicity of Cisplatinum (CDDP) in manBahmed, Y. / Dechaux, M. / Bassot, V. / Brasnu, D. / Kindermans, C. / Laccourreye, H. / Sachs, C. et al. | 1994
- 248
-
Prognostic factors in head and neck cancer patients included in a program of Neo-Adjuvant chemotherapy and radical radiotherapyCastillo, J. / Gomez, F. / Guerrero, R. / Sanchez, P. / Lopez, I. M. / Cueto, J. / Puche, J.-L. G. et al. | 1994
- 251
-
Induction chemotherapy for larynx preservation in laryngeal and hypopharyngeal cancersDemard, F. / Schneider, M. / Dassonville, O. / Chauvel, P. / Thyss, A. / Santini, J. et al. | 1994
- 257
-
A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neckGebbia, V. / Testa, A. / Valenza, R. / Zerillo, G. / Restivo, S. / Ingria, F. / Cannata, G. / Borsellino, N. / Gebbia, N. et al. | 1994
- 260
-
Concomitant radiotherapy and Cisplatin in head and neck cancer: a pilot studyOlmi, P. / Fallai, C. / Chiostrini, C. et al. | 1994
- 263
-
Ifosfamide/Mesna plus Carboplatin as Neo-Adjuvant therapy for stage I-III head and neck cancer. Preliminary reportBruno, M. et al. | 1994
- 267
-
Role of Ifosfamide, Cisplatinum (IC) combination in the metastatic neck nodesPai, V.-R. / Parikh, D.-M. / Mazumdar, A. T. / Rao, R. S. et al. | 1994
- 274
-
Clinical pharmacokinetics of Pure 1 Folinic Acid and Fluorouracil during a phase I-II trial of Fluorouracil biomodulation in head and neck cancer patients. Preliminary dataEtienne, M. C. / Milano, G. / Schneider, M. / Thyss, A. / Dassonville, O. / Bardon, M. / Guillot, T. / Demard, F. et al. | 1994
- 280
-
Long-term follow-up of the patients with recurrent or advanced head and neck cancer who received chemotherapy for palliationInuyama, Y. et al. | 1994
- 283
-
Intensified concomitant chemoradiotherapy for poor prognosis head and neck cancerVokes, E. E. / Haraf, D. J. / Moran, W. / Wenig, B. / Brachman, D. / Rubin, S. / McEvilly, J.-M. / Luckett, P. / Panje, W.-R. / Weichselbaum, R.-R. et al. | 1994
- 288
-
Response to chemotherapy of ulcerative lymphoma of the midfaceCabane, J. / Grange, C. / Lamas, G. / Meyer, B. / Godeau, P. / Imbert, J.-C. et al. | 1994
- 291
-
A multicentric study of the GETTEC (Groupe d'Etudes des Tumeurs de la Tete et du Cou) about 408 clinically complete responders after Neo-Adjuvant chemotherapy for head and neck carcinomasChauvel, P. / Lefebvre, J.-L. / Luboinski, B. / Kantor, G. / Bolla, M. / Andry, G. / Brugere, J. / Pessey, J.-J. / Demard, F. et al. | 1994
- 295
-
Chemotherapy of undifferentiated thyroid cancer (UCT) and sarcoma of the thyroid gland (ST)Kober, F. / Heiss, A. / Neugebauer, B. / Roka, R. et al. | 1994
- 298
-
Retinoid chemoprevention of aerodigestive carcinogenesisHong, W.-K. / Lippman, S.-M. / Benner, S.-E. / Lee, J.-S. et al. | 1994
- 303
-
Definite radiation and concomitant Cisplatin administration in locally advanced head and neck cancerFountzilas, G. / Skarlos, D. / Kosmidis, P. / Samantas, E. / Tzitzikas, J. / Makrantonakis, P. / Pantelakos, P. / Nicolaou, A. / Bacoyiannis, H. / Sinodinou, M. et al. | 1994
- 307
-
Improved survival of patients with advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapyBenasso, M. / Corvo, R. / Cavallari, M. / Sanguineti, G. / Margarino, G. / Rosso, R. / Vitale, V. / Merlano, M. / Members of affiliated institutions et al. | 1994
- 311
-
Treatment of patients with cancer of the head and neck or esophagus with carboplatin, 5-FU, Interferon-alpha and interleukin-2Schlappack, O. / Hainz, A. / Berghammer, P. / Grasl, M. / Kautzky, M. / Kment, G. / Dobrowsky, W. / Dittrich, C. et al. | 1994
- 315
-
Surgical considerations in the treatment of well-differentiated thyroid cancerRoisman, I. / Barak, V. / Sapir, D. / Bitterman, A. / Livni, N. / Honigman, J. / Gimmon, Z. / Manny, J. / Durst, A. L. et al. | 1994
- 319
-
Intensive chemotherapy with recombinant-human granulocyte-macrophage colony stimulating factor (r-hu-gm-csf) for small cell lung cancer (sclc): a pilot studyBesana, C. / Bucci, E. / Borri, A. / Di Lucca, G. / Tognella, S. / Tresoldi, M. / Marcatti, M. / Corti, C. / Citterio, G. / Inversi, F. et al. | 1994
- 322
-
Sequential high-dose chemotherapy with r-metHu-G-CSF (Filgrastim) and infusion of peripheral blood progenitor cells (PBPC) in patients with small cell lung cancer (SCLC). A feasibility studyLeyvraz, S. / Ketterer, N. / Grob, J. P. / Schneider, P. / Vuichard, P. / von Fliedner, V. / Lejeune, F. et al. | 1994
- 328
-
Cisplatinum and 5-Fluorouracil in small cell lung cancerMorere, J. F. / Duran, A. / Tcherakian, F. / Boaziz, C. / Battesti, J. P. / Israel, L. / Breau, J. L. et al. | 1994
- 331
-
Phase I-II study of oral Etoposide and modulation of drug resistance with ketoconazole in small cell lung cancerDalley, D. / Brigham, B. et al. | 1994
- 336
-
Angiogenesis: a novel target for Adjuvant chemotherapy in locally advanced non-small cell lung cancerMacchiarini, P. / Fontanini, G. / Dulmet, E. / de Montpreville, V. / Chapelier, A. / Lenot, B. / Cerrina, J. / Le Roy Ladurie, F. / Dartevelle, P. et al. | 1994
- 343
-
A statistical model for investigating Adjuvant chemotherapy in T1N0M0 non-small cell lung cancerHardin, J. M. / Macchiarini, P. / Singh, K. P. et al. | 1994
- 348
-
A combination chemotherapy with Ifosfamide (I), Cisplatin (P) and Etoposide (E) for advanced non-small cell lung cancer (NSCLC)Martin, G. / Garcia, M. J. / Cruz, J. J. / Gomez, A. / Panadero, A. / Fonseca, E. / Sanchez, P. / Soria, P. / Garcia, J. / Vallejo, J. C. et al. | 1994
- 351
-
Mitomycin, Ifosfamide and Platin (MIP) in advanced and disseminated non-small cell lung cancer (NSCLC)Souquet, P. J. / Bohas, C. / Zenone, T. / Michaud, E. / el Khoury, M. T. / Romestaing, P. / Bernard, J. P. et al. | 1994
- 354
-
Phase III randomized study of Neo-Adjuvant chemotherapy surgery in non-small cell lung cancer (NSCLC) preliminary resultsDepierre, A. / Milleron, B. / Chastang, C. / Lebeau, B. / Terrioux, P. / Quoix, E. / Moro, D. / Miech, G. / Paillot, N. / Breton, J. L. et al. | 1994
- 357
-
Vinorelbine, 5-Fluorouracil, Folinic acid and Cisplatin in non-small cell lung cancer: Vindesine for Vinorelbine?de Cremoux, H. / Monnet, I. / Azli, N. / Voisin, S. / Ruffie, P. / Vergnes, L. / Huet, J. / Saltiel, J. C. / Armand, J. P. / Cvitkovic, E. et al. | 1994
- 362
-
Preoperative chemotherapy in non-small cell lung cancer (NSCLC) - A pilot studyFischer, J. R. / Manegold, C. / Branscheid, D. / Vogt-Moykopf, I. / Drings, P. et al. | 1994
- 366
-
Neo-Adjuvant Cisplatin and Etoposide for stage IIIA (clinical N2) non-small cell lung cancerDarwish, S. / Minotti, V. / Rossetti, R. / Ciccarese, G. / Crino, L. / Fiaschini, P. / Mercati, U. / Maranzano, E. / Latini, P. / Tonato, M. et al. | 1994
- 370
-
Concomitant chemoradiotherapy with Cisplatin dose escalation as palliative therapy for advanced malignancies of the chestDrinkard, C. L. / Haraf, J. D. / Hoffman, C. P. / Golomb, M. H. / Ferguson, K. M. / Vogelzang, J. N. / Vokes, E. E. et al. | 1994
- 375
-
Concomitant chemoradiotherapy for inoperable non-small cell carcinoma of the lung: results of continuous infusion Cisplatin in 85 patientsReboul, F. / Vincent, P. / Chauvet, B. / Brewer, Y. / Faure, C. F. / Taulelle, M. et al. | 1994
- 377
-
Late results of Neo-Adjuvant chemoradiotherapy for primary inoperable non-small cell lung cancerRebischung, J. L. / Vannetzel, J. M. / Dartevelle, P. et al. | 1994
- 383
-
Conservative treatment of esophagus cancer concomitant chemoradiotherapy treatment. First results of a 143 patients serialJacob, J. H. / Roussel, A. / Ollivier, J. M. / Izard, J. P. / Vernhes, J. C. et al. | 1994
- 386
-
Induction chemotherapy, surgery and concomitant chemoradiotherapy for carcinoma of the esophagusHoffman, P. C. / Ferguson, M. K. / Haraf, D. J. / Drinkard, L. C. / Golomb, H. M. / Vokes, E. E. et al. | 1994
- 389
-
Superiority of combined chemoradiotherapy to radiotherapy alone in patients with esophageal cancers. An intergroup studyAl-Sarraf, M. / Martz, K. / Herskovic, A. / Leichman, L. / Brindle, J. S. / Vaitkevicius, V. K. / Cooper, J. / Byhardt, R. / Davis, L. / Emami, B. et al. | 1994
- 393
-
Neo-Adjuvant chemoradiotherapy for advanced gastric cancer: a pilot study with angiotensin II induced drug delivery systemSugiyama, K. / Sato, H. / Hoshi, M. / Urushiyama, M. / Ishizuka, K. / Kanamaru, R. et al. | 1994
- 396
-
Combination of 5-FU, Leucovorin and Cisplatin (CDDP): an efficient low-toxic chemotherapy in advanced gastric adenocarcinomaYchou, M. / Fedkovic, Y. / Christopoulou, A. / Saint-Aubert, B. / Rouanet, P. / Astre, C. / Pujol, H. et al. | 1994
- 399
-
Adjuvant chemotherapy and radiotherapy in liver transplantation for primary hepatocellular carcicoma: a feasibility studyPierga, J.-Y. / Pied-bois, P. / Cherqui, D. / Duvoux, C. / Ramouni, A. / Metreau, J.-M. / Mathieu, D. / Julien, M. / Dhumeaux, D. / Fagniez, P.-L. et al. | 1994
- 405
-
Intensive weekly chemotherapy for advanced gastric cancer using 5-Fluorouracil, Cisplatin, Epirubicin, 6S-Leucovorin and Granulocyte-colony stimulating factorCascinu, S. / Fedeli, A. / Fedeli, S. L. / Catalano, G. et al. | 1994
- 411
-
Neo-Adjuvant chemotherapy for inoperable gastric cancer via local and general delivery routes (FLEP Therapy)Nakajima, T. / Ishihara, S. / Motohashi, H. / Kitamura, Y. / Nakajima, Y. / Fujii, M. / Tokunaga, A. / Matai, K. / Anzai, H. / Nishi, M. et al. | 1994
- 414
-
Gastric cancer - a place for preoperative induction regional chemotherapyStorey, B. Y. D. W. / Gallagher, P. J. / Waugh, R. C. / Stephens, F. O. et al. | 1994
- 419
-
alpha-2b-Interferon (IFN) plus chemotherapy in inoperable biliary-tract carcinoma, preliminary dataFrasci, G. / Monaco, M. / Cremone, L. / Sapio, U. / Faiella, F. / Persico, G. et al. | 1994
- 422
-
A phase II study of weekly 48 hours infusion with high-dose Fluorouracil (FU) in colorectal cancerAranda, E. / Diaz-Rubio, E. / Camps, C. / Fernandez-Marto, C. / Carrato, A. / Anton, A. / Cervantes, A. / Cruz-Hernandez, J. J. / Tres, A. / Belon, J. et al. | 1994
- 428
-
Phase II trial of Fluorouracil, Leucovorin and Interferon-alphaBukowski, R. M. / Gibson, V. / Murthy, S. / McLain, D. / Olencki, T. / Budd, G. T. et al. | 1994
- 433
-
Continuous simultaneous intra-arterial and intravenous therapy of liver metastases of colorectal carcinoma. Results of a prospective randomized studySafi, F. / Link, K. H. / Beger, H. G. et al. | 1994
- 441
-
D-Verapamil and Adriamycin in the treatment of advanced colorectal cancerScheithauer, W. / Kornek, G. / Globitz, S. / Raderer, M. / Schenk, T. / Muller, C. H. / Tetzner, C. H. et al. | 1994
- 444
-
Perioperative multimodal treatment of locally advanced rectal cancer. Results of a pilot studySchoffski, P. / Raab, H. R. / Wildfang, I. / Kohne-Wompner, C. H. / Karstens, J. H. / Pichlmayr, R. / Schmoll, H. J. et al. | 1994
- 453
-
Neo-Adjuvant chemotherapy for advanced ovarian cancerShimizu, Y. / Umezawa, S. / Takeshima, N. / Kato, T. / Hasumi, K. et al. | 1994
- 460
-
Hyperfractionation using weekly Cisplatin, Cyclophosphamide and Adriamycin (CAP) in advanced epithelial tumors of the ovaryTonkin, K. / Levin, L. et al. | 1994
- 464
-
Adjuvant treatment of ovarian carcinomaVergote, I. B. / Trope, C. G. / De Vos, L. N. / Kaern, J. / Abeler, W. M. / Winderen, M. / Pettersen, E. O. et al. | 1994
- 469
-
Cyclophosphamide (CTX) and high-dose 4-Epidoxorubicin (EPI) in advanced ovarian cancer (OC) treatmentCartei, G. / Signor, M. / Vigevani, E. / Giovannoni, M. / Sibau, A. / Clocchiatti, G. / Mansutti, M. et al. | 1994
- 473
-
High-dose chemotherapy (HDC) and autologous bone marrow transplant (ABMT) in 39 advanced ovarian cancers: long-term resultsLegros, A. / Cure, H. / Fleury, J. / Suzanne, F. / Dauplat, J. / Chollet, P. / Plagne, R. et al. | 1994
- 476
-
Concomitant chemotherapy and radiotherapy in the treatment of advanced cervix carcinomasResbeut, M. / Noirclero, M. / Gravis, G. / d Ercole, C. / Pechikoff, P. / Houvenaeghel, G. / Delpero, J. R. / Blache, J. L. / Viens, P. et al. | 1994
- 479
-
Adjuvant chemotherapies for small cell carcinoma of the uterine cervixChang, T. C. / Chang, H. C. / Lai, C. H. / Hsueh, S. / Huang, S. F. / Chang, H. K. / Soong, Y. K. et al. | 1994
- 482
-
Neo-Adjuvant M-VAC (Methotrexate, Vinblastine, Doxorubicin, Cisplatin) chemotherapy for locally advanced or metastatic cervical and vaginal cancerGarton, G. R. / Wilson, T. O. / Hartmann, L. C. / Long, H. J. / Podratz, K. C. et al. | 1994
- 485
-
A phase II trial of Neo-Adjuvant chemotherapy (CT) with Ifosfamide (I), Mesna and Cisplatinum (C) in stage IIA-IIIB cervical cancerErazo, A. / Torrecillas, L. / Cervantes, G. / Ortega, B. et al. | 1994
- 488
-
Bleomycin, Ifosfamide and Carboplatin in advanced uterine cervix carcinoma: preliminary resultsLouvet, C. / Moreau, S. / de Gramont, A. / Varette, C. / Demuynck, B. / Beerblock, K. / Marpeau, L. / Zylberait, D. / Pigne, A. / Soubrane, D. et al. | 1994
- 495
-
Surveillance in stage I non-seminomatous germ cell tumors of the testis (NSGCTT). Experience at the Instituto Nacional de Cancerologia of MexicoZinser, J. W. / Gaona, R. / Mendoza, A. / Ocampo, O. / Dominguez, H. / Vicencio, L. et al. | 1994
- 499
-
Combination chemotherapy with Etoposide, Cisplatin, Bleomycin and Cyclophosphamide for advanced metastatic non-seminomatous germ cell tumorsGerl, A. / Clemm, C. / Hentrich, M. / Hartenstein, R. / Kohl, P. / Wilmanns, W. et al. | 1994
- 503
-
Extended resection after primary chemotherapy for residual malignant non-seminomatous germ cell tumors of the mediastinum: is it worthwhile?Macchiarini, P. / Dulmet, E. / de Montpreville, V. / Chapelier, A. / Lenot, B. / Cerrina, J. / Dartevelle, P. et al. | 1994
- 510
-
The prediction of treatment outcomes in non-seminomatous extragonadal germ cell tumors (NSEGCT) by using different criteria of << poor >> and << good >> riskDelgado, F. G. / Garin, A. / Tjulandin, S. / Mendoza, M. R. / Khlebnov, A. et al. | 1994
- 513
-
Advanced seminoma treated with chemotherapy (CT)Zinser, J. W. / Gaona, R. / Mendoza, A. / Ocampo, O. / Dominguez-Malagon, H. / Gomez, E. / Vicencio, L. et al. | 1994
- 516
-
Concomitant 5-FU-CDDP and bifractioned split course radiation therapy for invasive bladder cancerMaulard, C. / Housset, M. / Chretien, Y. / Delanian, S. / Colardelle, F. / Hallez, J. P. / Dufour, B. / Baillet, F. et al. | 1994
- 520
-
Neo-Adjuvant treatment for locally advanced bladder cancer: a randomized prospective clinical trialPellegrini, A. / Cortesi, E. / Gioacchini, N. / Ballatori, E. / Virdis, R. A. et al. | 1994
- 523
-
Ultrastructural and clinical study of the urothelium after Interferon-alpha-2b treatmentStravoravdi, P. / Belivanis, J. / Dimopoulos, T. / Hatzigianis, J. / Polyzonis, M. et al. | 1994
- 527
-
Chemoradiotherapy in locally advanced bladder cancer: Neo-Adjuvant and definitive treatmentCanobbio, L. / Boccardo, F. / Curotto, A. / Pace, M. / Guarneri, D. / Rubagotti, A. / Venturini, M. / Orsatti, M. / Vitale, V. / Schenone, M. et al. | 1994
- 535
-
Interferon-alpha (IFN-alpha) combined with 5-Fluorouracil (5-FU) is an active regimen in metastatic renal cell cancerSella, A. / Finn, L. / Amato, R. / Logothetis, C. et al. | 1994
- 540
-
Comparative efficacy of hormonal therapy used alone or in combination for treatment of prostatic carcinomaMulloy, W. et al. | 1994
- 542
-
Etoposide in treatment of hormone refractory advanced carcinoma of the prostateDaneshgari, M. D. F. / Crawford, E. D. / Suzan, B. A. / Majeski, A. et al. | 1994
- 548
-
Sequential therapy with recombinant Interleukin-2 (rIL-2) and alpha-Interferon (IFN) for advanced renal cell cancer (rcc): a preliminary reportBesana, C. / Bucci, E. / Borri, A. / Schoenheit, A. / Citterio, G. / Matteucci, P. / Tognella, S. / Baiocchi, C. / Landonio, G. / Ghislandi, E. et al. | 1994
- 551
-
No advantage for the use of an early high-dose chemotherapy with autologous bone marrow transplantation in first-line treatment of poor risk non-seminomatous germ cell tumorsCure, H. / Droz, J. P. / Pico, J. L. / Biron, P. / Kerbrat, P. / Chevreau, C. / Heron, J. F. / Chevallier, B. / Fargeot, P. / Bouzy, J. et al. | 1994
- 557
-
Initial experience with autologous transplantation of 7 days noncryopreserved peripheral blood stem cells, mobilized with G-CSF, in rhabdomyosarcomaSobrevilla-Calvo, P. / Reynoso-Gomez, E. / de la Garza-Salazar, J. et al. | 1994
- 561
-
High-dose chemotherapy with granulocyte colony-stimulating factor in advanced and/or metastatic soft tissue sarcomasToma, S. / Palumbo, R. / Folco, U. / Canavese, G. / Aitini, E. / Cantoni, E. / Vincenti, M. / Rosso, R. et al. | 1994
- 565
-
Treatment of osteosarcoma with Cisplatin and Doxorubicin either as Adjuvant or Neo-Adjuvant chemotherapyZinser, J. W. / Castaneda, N. / Alfeiran, A. / Maafs, E. / Duran, M. / Flores, G. / Gaona, R. / Vicencio, L. et al. | 1994
- 568
-
The role of preoperative and Adjuvant chemotherapy in the treatment on non rhabdomyosarcoma soft tissue sarcoma in children and adolescentsGross-Wieltsch, U. / Morgan, M. / Koscielniak, E. / Treuner, J. et al. | 1994
- 573
-
Escalating doses of Epirubicin in combination with Ifosfamide and GM-CSF in previously untreated soft tissue sarcoma patients; a phase I-II studyFrustaci, S. / Buonadonna, A. / Favaro, D. / Santarosa, M. / Latini, F. / Lamon, S. / Galligioni, E. / Monfardini, S. et al. | 1994
- 577
-
Primary chemotherapy in malignant fibrous histiocytoma of bone - Updated UTMD Anderson Cancer Center ExperiencePatel, S. R. / Armen, T. / Carrasco, C. H. / Raymond, A. K. / Ayala, A. G. / Murray, J. A. / Chawla, S. P. / Benjamin, R. S. et al. | 1994
- 581
-
Concomitant radiation-Doxorubicin administration in locally advanced and/or metastatic soft tissue sarcomasToma, S. / Palumbo, R. / Grimaldi, A. / Barra, S. / Canavese, G. / Castagneto, B. / Frola, C. / Aitini, E. / Rosso, R. et al. | 1994
- 587
-
Chemotherapy as a first treatment for malignant primary CNS non-Hodgkin's lymphoma of the central nervous system (PCNSL)Boiardi, A. / Silvani, A. / Salmaggi, A. / Valentini, S. / Allegranza, A. / Broggi, G. et al. | 1994
- 590
-
Effect of six retinoids and retinoic acid catabolic inhibitor liarozole on two glioblastoma cell lines, and in vivo experience in malignant brain tumor patientsWestarp, M. E. / Westarp, M. P. / Bollag, W. / Bruynseels, J. / Biesalski, H. / Grossmann, N. / Kornhuber, H. H. et al. | 1994
- 599
-
Phase II trial with BCNU plus alpha-2B-Interferon in patients with recurrent high-grade gliomasBrandes, A. / Zampieri, P. / Rigon, A. / Scelzi, E. / Zorat, P. L. / Rotilio, A. / Amista, P. / Paccagnella, A. / Fiorentino, M. V. et al. | 1994
- 604
-
Carboplatin combined with Carmustine and Etoposide in the treatment of glioblastoma (GBM) patientsBoiardi, A. / Silvani, A. / Valentini, S. / Salmaggi, A. / Botturi, M. / Farinotti, M. / Giorgi, C. et al. | 1994
- 607
-
Phase II trial of Cystemustine, a new nitrosourea, as second-line treatment of malignant gliomasTisserant, A. / Plagne, R. / Roche, H. / Adenis, A. / Fargeot, P. / Guiochet, N. / Cattan, P. / Krakowsky, Y. / Lentz, M. A. / Fumoleau, P. et al. | 1994
- 612
-
Age effect on the survival of patients with glioblastoma and anaplastic astrocytomaHildebrand, J. / The EORTC Brain Tumour Group et al. | 1994
- 616
-
Concurrent radiochemotherapy in high-grade gliomaBrandes, A. / Zampieri, P. / Rigon, A. / Scelzi, E. / Pignatarox, M. / Berti, F. / Rotilio, A. / Padoan, A. / Amista, P. / Paccagnella, A. et al. | 1994
- 620
-
Interferon-alpha-2b + fotemustine in disseminated malignant melanomaKowalzick, L. / Mohr, P. / Weichenthal, M. / Langenbahn, H. / Hossfeld, D. K. / Breitbart, E. W. et al. | 1994
- 623
-
Tamoxifen-augmented biochemotherapy (Interferon-alpha-2b, Tamoxifen, BCNU, CDDP, DTIC) for malignant melanomaVoigt, H. / Classen, R. / Ramaker, J. et al. | 1994
- 631
-
Chemofiltration for locally advanced cancerInbar, M. / Gutman, M. / Chaitchik, S. / Klausner, J. M. et al. | 1994
- 635
-
Treatment optimization guidelines for hyperthermic antiblastic limb perfusionPace, M. / Millanta, L. / Galli, A. / Bellacci, A. et al. | 1994
- 639
-
5-FU + Folinic Acid (FA, Rescuvolin®) i.a., 5-FU + FA i.v., 5-FUDR i.a., or 5-FUDR i.a. + i.v. for treatment of non-resectable colorectal liver mestastases?Link, K. H. / Kreuser, E. D. / Safi, F. / Schalhorn, A. / Schmoll, E. / Pillasch, J. / Beger, H. G. et al. | 1994
- 649
-
Hepatic arterial chemotherapy (HAI) for unresectable liver metastases from gastrointestinal cancerMusca, F. / Esposito, R. / Toma, G. et al. | 1994
- 652
-
The treatment of presacral recurrences of rectal cancer by the use of loco-regional pelvic chemotherapy. A discussion of these methods as a Neo-Adjuvant time in locally advanced rectal tumorsManivit, P. / Polo, R. / Tabary, D. / Nabet, M. / Polo, M. / Rubini, B. / Chipponi, P. N. / Fromaget, J. M. / Untereiner, M. et al. | 1994
- 658
-
Repeated chemo-occlusion with Degradable Starch Microspheres (DSM) - Enhanced drug uptake and regional efficacy in the treatment of primary and secondary liver tumorsNilsson, B. / Johansson, C. J. / Bunke, B. / Taguchi, T. et al. | 1994
- 665
-
Antitumor efficacy of intraperitoneal hyperthermochemotherapy combined with aggressive surgery for patients with advanced gastric cancerFujimoto, S. / Takahashi, M. / Kobayashi, K. / Mutou, T. / Kure, M. / Masaoka, H. / Ohkubo, H. et al. | 1994
- 669
-
Intraperitoneal hyperthermic chemoperfusion in patients with peritoneal carcinomatosis and malignant ascitesKober, F. / Neugebauer, B. / Heiss, A. / Roka, R. et al. | 1994
- 672
-
Intra-aortic infusion chemotherapy in advanced penile carcinomaSheen, M. C. / Sheu, H. M. / CHai, C. Y. / Huang, C. H. / Wang, Y. W. et al. | 1994
- 677
-
The influence of both surgery and Adjuvant chemotherapy on breast cancer women quality of lifeCaffo, O. / Ambrosini, G. / Agugiaro, S. / Eccher, C. / Maluta, S. et al. | 1994
- 681
-
Psychological side effects induced by Interleukin-2/alpha-Interferon: clinical observations, biological correlationsSmith, M. J. / Mouawad, R. / Vuillemin, E. / Benhammouda, A. / Soubrane, C. / Khayat, D. et al. | 1994
- 691
-
Quality of life in advanced colorectal cancerFrancini, G. / Petrioli, R. / Aquino, A. / Marsili, S. / Bruni, S. / Lorenzini, L. / Mancini, S. / Lorenzi, M. / Marzocca, G. / Tani, F. et al. | 1994
- 695
-
Advance directives in the intensive care unit of a tertiary cancer centerEwer, M. S. / Taubert, J. / Ali, M. K. et al. | 1994
- 699
-
Do cancer related pain problems exist in France?Brasseur, L. / Larue, F. / Dubiez, M. / Colleau, S. / Cleeland, C. et al. | 1994
- 702
-
Intravenous granisetron-simple, safe and effective single-dose. Administration for control of chemotherapy induced nausea and vomitingDilly, S. G. et al. | 1994
- 705
-
Control of refractory nausea and vomiting with adjuvant propofol during cancer chemotherapyBorgeat, A. / Wilder-Smith, O. H. G. / Rifat, K. / Forni, M. et al. | 1994
- 707
-
Liposomal Daunorubicin treatment increases quality of life in HIV-associated Kaposi's SarcomaPresant, C. A. / Scolaro, M. / Kennedy, P. / Blayney, D. W. / Flanagan, B. / Lisak, J. / Presant, J. et al. | 1994
- 713
-
Comparison of 12 multidrug-resistance modulating agents in a model of doxorubicin-resistant rat glioblastoma cells in vitroRobert, J. / Huet, S. / Bennis, S. / Chapey, C. et al. | 1994
- 720
-
Differential formation, repair and tolerance of Cisplatin-induced DNA damage in two human small cell lung carcinoma cell linesHill, B. T. / Shellard, S. A. et al. | 1994
- 723
-
Identification of a distinctive multiple drug resistance phenotype in tumour cells following in vitro exposure to X-irradiationHill, B. T. / Whelan, R. H. D. / McClean, S. et al. | 1994
- 726
-
Functional activity of P-glycoprotein localized in subcellular structures and reversal of multidrug resistance (MDR)Toffoli, G. / Tumiotto, L. / Dall Arche, M. G. / Cernigoi, C. / Boiocchi, M. et al. | 1994
- 730
-
New strategy for the production of monoclonal antibodies to external portion of the P-glycoproteinPage, M. / Yang, X. / Roby, P. / Paradis, R. / Berkova, N. et al. | 1994
- 736
-
Myeloperoxidase is involved in Vincristine resistance in human myeloblastic leukemiaSchlaifer, D. / Cooper, M. R. / Attal, M. / Sartor, A. O. / Trepel, J. B. / Muller, C. / Laurent, G. / Myers, C. E. et al. | 1994
- 740
-
A new multidrug resistance modulating agent S 9788: preliminary report of the phase clinical trial in combination with VincristineKhayat, D. / Benhammouda, A. / Weil, M. / Vuillemin, E. / Bastian, G. / Antoine, E. / Rixe, O. / Auclerc, G. / Lucas, C. / Sarkany, M. et al. | 1994
- 745
-
Effect of Pentoxifylline, ethacrynic acid and O^6-benzyl-guanine as resistance modifiers to alkylating agents in haematological malignanciesMuller, M. R. / Schlenger, L. / Boogen, C. / Nowrousian, M. R. / Seeber, S. et al. | 1994
- 749
-
Structural alterations of human topoisomerase IIalpha responsible for drug-resistance, DNA-binding and nuclear localizationBoege, F. / Gieseler, F. / Meyer, P. et al. | 1994
- 757
-
Measurement of human tumor pharmacokinetics in vivo noninvasively by 19-F magnetic resonance spectroscopy predicts clinical 5-FU sensitivity and resistancePresant, C. A. / Wolf, W. / Waluch, V. / Brechner, R. / Wiseman, C. / Blayney, D. W. / Kennedy, P. et al. | 1994
- 759
-
Immunoregulation by tumor necrosis factor alpha (TNF): an opportunity for therapeutic intervention?Mihich, E. / Maccubbin, D. / Pocchiari, S. / Ujhazy, S. / Verstovsek, S. / Ehrke, M. J. et al. | 1994
- 765
-
Tumor necrosis factor alpha: its relationship with clinical dataLopez, J. J. B. / Escobar, M. / Gallurt, P. / Rodriguez, P. / Lorenzo, A. / Moran, A. / Senra, A. / Millan, J. et al. | 1994
- 770
-
The antiproliferative effect of lymphoblastoid alpha interferon and its ability to re-induce or amplify major histocompatibility complex antigen expression on human renal carcinoma cells in cultureAngus, R. L. / Collins, C. M. P. / Symes, M. O. et al. | 1994
- 774
-
Is there any predictive factor of the clinical response to IL-2 therapy in metastatic malignant melanoma?Soubrane, C. / Mouawad, R. / Ichen, M. / Suissa, J. / Vuillemin, E. / Borel, C. / Benhammouda, A. / Weil, M. / Khayat, D. et al. | 1994
- 779
-
How IL-2 can affect melanoma cellsPlaisance, S. / Alileche, A. / Rubinstein, E. / Han, D. / Azzarone, B. / Jasmin, C. et al. | 1994
- 785
-
Potentiation of 5-Fluorouracil-[6RS]leucovorin cytotoxicity by recombinant human Interferon-alpha2A in colon carcinoma cellsHoughton, J. A. / Adkins, D. A. / Houghton, P. J. et al. | 1994
- 789
-
Evidence for a role of immunosuppression in the pathogenesis of small cell lung cancerFischer, J. R. / Schindel, M. / Stein, N. / Lahm, H. / Gallati, H. / Drings, P. / Krammer, P. H. et al. | 1994
- 794
-
p53 expression in human soft tissue sarcomas. Correlation with biological aggressivenessToffoli, G. / Perin, T. / Doglioni, C. / Frustaci, S. / Buonadonna, A. / de Paoli, A. / Cernigoi, C. / Tumiotto, L. / Dall Arche, M. G. / Boiocchi, M. et al. | 1994
- 798
-
Synergistic cytotoxicity as an endpoint for the development of rational chemotherapeutic. Drug combinationsAbbruzzese, J. L. / Frost, P. et al. | 1994
- 804
-
5-Fluorouracil may have different mechanisms of action depending on the dose schedule: clinical implicationsAschele, C. / Sobrero, A. / Guglielmi, A. / Mori, A. / Tixi, L. / Bolli, E. / Rosso, R. / Bertino, J. R. et al. | 1994
- 809
-
Clinical studies of CPT-11 in JapanTaguchi, T. et al. | 1994
- 813
-
Evaluation of CPT-11 against human xenografts of colon adenocarcinoma and childhood sarcomasHoughton, P. J. / Hougthon, J. A. et al. | 1994
- 817
-
Microencapsulation, Tamoxifen analogues, and in vivo microscopy for tumor targetingYang, D. / Wallace, S. / Kuang, L.-R. / Li, C. / Cherif, A. / Kan, Z. / McCuskey, P. / Wright, K. C. et al. | 1994
- 820
-
A new generation of Doxorubicin-loaded liposomes with improved localization in tumors: preclinical and clinical studiesGabizon, A. / Uziely, B. / Kaufman, B. / Safra, T. / Catane, R. / Barenholz, Y. et al. | 1994
- 823
-
Degradable starch microspheres increase the cytostatic effect of the bioreductive drug RSU-1069 (aziridine 2-nitroimidazole) at arterial administration in rats with a liver carcinomaStenram, U. / Roos, G. et al. | 1994
- 826
-
Therapeutic use of polyspecific mab-labelled liposomes as carriers for radioisotopes and drugsRombi, G. / Cossu, F. / Melis, G. / Anedda, V. / Facchini, A. et al. | 1994
- 833
-
An in vitro model for neutrophil-mediated damage to tumour vasculature: effects of a novel anti-cancer agentMurray, J. C. / Smith, K. A. / Bastaki, M. / Wilson, K. B. et al. | 1994
- 838
-
Stimulation of tumor growth in-vitro and in-vivo by Suramin in an experimental modelJulieron, M. / Ramirez, L. / Bonnay, M. / Vassal, G. / Gavoille, A. / Piron, D. / Gandia, D. / Mir, L. / Munck, J.-N. et al. | 1994
- 843
-
Phase I-II trial of Seraspenide (AcSDKP): a suppressor of myelopoiesis protects against chemotherapy myelotoxicity (version 10 february 1993)Carde, P. / Goncalves, E. / Isnard, F. / de Paillette, E. D. / Chastang, C. / Mathieu-Tubiana, N. / Vuillemin, E. / Delwail, V. / Corbion, O. / Vekhoff, A. et al. | 1994
- 850
-
A review on the use of sheep epidermal squamous cell carcinoma to evaluate intra-arterial infusion chemotherapyHarker, G. J. S. / Stephens, F. O. et al. | 1994
- 855
-
Cellular and pharmacokinetic factors which influence genotoxicity of topoisomerase II inhibiting drugs in human leukemia cellsGieseler, F. / Nussler, V. / Boege, F. / Biller, D. / Meyer, P. / Willmanns, W. / Wilms, K. et al. | 1994
- 861
-
Clinical application of gene transfer in oncology: preliminary results of a French studyMerrouche, Y. / Bain, C. / Clapisson, G. / Negrier, S. / Coronel, B. / Mercatello, A. / Moskovtchenko, J.-F. / Moen, B. / Philip, T. / Favrot, M. C. et al. | 1994
- 865
-
Effects of Vitamin-A on the oestrogen dependant breast carcinoma cell line ZR75-1Horgan, P. G. / O Donoghue, J. / Byrne, J. / Phelan, C. / Given, H. F. et al. | 1994
- 871
-
Measurement of the early level of mdr1 gene expression is a predictive marker of tumour response in breast cancer patients treated by Neo-Adjuvant chemotherapyPierga, J. Y. / Chevillard, S. / Pouillart, P. / Vielh, P. et al. | 1994
- 875
-
Hematologic effects of recombinant human Interleukin-6 (rhIL-6) in sarcoma patients receiving maid chemotherapy: phase I trialBukowski, R. M. / Isaacs, R. / Gordon, M. / Demetri, G. D. / Amuels, B. / Young, D. C. / Samuel, S. / McLain, D. / Levitt, D. et al. | 1994
- 880
-
Role of G-CFS and GM-CSF in the treatment of febrile neutropenia induced by chemotherapy; preliminary results of a randomized trialRivera, F. / Mayordomo, J. I. / Diaz-Puente, M. T. / Lianes, M. P. / Lopez-Brea, M. / Lopez, E. / Paz-Ares, L. / Alonso, S. / Cortes-Funes, H. et al. | 1994
- 885
-
First line chemotherapy for patients with multiple myeloma with vad regimen followed by consolidation with high-dose chemoradiotherapy with peripheral stem cells autograft (PSCA): the experience of IGR centerBrault, P. / Gilles, E. / Ibrahim, A. / Beaujean, F. / Jimenz, S. / Tertian, G. / Hayat, M. / Bourhis, J. H. / Pico, J. L. et al. | 1994